An evaluation of the efficacy of a single-session 577 nm pro-yellow laser treatment in patients with postacne erythema and scarring
dc.authorid | Cenk, Hülya/0000-0003-4871-6342 | |
dc.authorwosid | Cenk, Hülya/A-1293-2016 | |
dc.contributor.author | Sarac, Gulbahar | |
dc.contributor.author | Kapicioglu, Yelda | |
dc.contributor.author | Cenk, Hulya | |
dc.date.accessioned | 2024-08-04T20:49:07Z | |
dc.date.available | 2024-08-04T20:49:07Z | |
dc.date.issued | 2021 | |
dc.department | İnönü Üniversitesi | en_US |
dc.description.abstract | Erythema and scarring are among the most common complications of severe inflammatory acne. In this study, we aimed to share our experience with pro-yellow laser and document the efficacy and safety of this treatment in postacne erythema and scarring. The study included 40 patients, 24 (60%) females, and 16 (40%) males with a mean age of 29.5 +/- 8.16 (min. 18 years, max. 57 years). The pro-yellow laser was applied to all patients as a single session with irradiation of 22 J/cm(2). Improvement in postacne erythema and scars were evaluated after the treatment. The study included 40 patients, 24 patients (60%) were females and 16 patients (40%) were males with the mean age of 29.5 +/- 8.16 (ranged between 18 and 57 years old). A total of 21 patients (52.5%) had good improvement (51%-75% regression), 10 patients (25%) had excellent improvement (76%-100% regression), and a moderate improvement (26%-50%) was detected in 9 patients (22.5%). Also, there were mild improvement (1%-25%) in 20 patients (76.9%) and a moderate improvement (26%-50%) in 6 patients (23.1%). We found that pro-yellow laser is highly effective in the treatment of postacne erythema, while its effectiveness was mild to moderate in atrophic acne scars. Also, it has been observed that the pro-yellow laser system can be used safely immediately after cessation of systemic isotretinoin treatment. | en_US |
dc.identifier.doi | 10.1111/dth.14611 | |
dc.identifier.issn | 1396-0296 | |
dc.identifier.issn | 1529-8019 | |
dc.identifier.issue | 1 | en_US |
dc.identifier.pmid | 33258538 | en_US |
dc.identifier.scopus | 2-s2.0-85097404609 | en_US |
dc.identifier.scopusquality | Q1 | en_US |
dc.identifier.uri | https://doi.org/10.1111/dth.14611 | |
dc.identifier.uri | https://hdl.handle.net/11616/99664 | |
dc.identifier.volume | 34 | en_US |
dc.identifier.wos | WOS:000597184200001 | en_US |
dc.identifier.wosquality | Q3 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.indekslendigikaynak | Scopus | en_US |
dc.indekslendigikaynak | PubMed | en_US |
dc.language.iso | en | en_US |
dc.publisher | Wiley | en_US |
dc.relation.ispartof | Dermatologic Therapy | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/openAccess | en_US |
dc.subject | postacne erythema | en_US |
dc.subject | postacne erythema treatment | en_US |
dc.subject | postacne scarring | en_US |
dc.subject | pro? yellow laser | en_US |
dc.subject | vascular laser | en_US |
dc.title | An evaluation of the efficacy of a single-session 577 nm pro-yellow laser treatment in patients with postacne erythema and scarring | en_US |
dc.type | Article | en_US |